Skip to the guide Regenerative Providers A care-search workbook Getting started A plain-language guide to checking care Regenerative providers. Check the offer first. Regenerative means regrowth or repair. If your search has led to peptide care, begin with the treatment’s exact name. Protein building blocks linked in a small chain form a peptide. Then check the person, the product, and the full price. Take the question sheet A clear answer is a fair ask. Make room for your questions. The word is only a start Calling something a peptide does not settle whether it is safe or legal in the U.S., as of September 2026. Source A Make the offer clear What kind of product is it? The word regenerative does not name the treatment being offered. Ask for its exact name, what it is meant to treat, and which type of product below it is. FDA is short for Food and Drug Administration, the U.S. drug agency. FDA-approved medicine Semaglutide is in two medicines: Ozempic, used for type 2 diabetes, and Wegovy, used for weight loss. These products have U.S. approval as of September 2026. Approval is for a named product and a particular use, not for every treatment called a peptide. Ask which product is being offered and what condition it is meant to treat. Source B Compounded medicine With compounding, a licensed pharmacist or doctor prepares medicine for a patient rather than providing a ready-made drug. As of September 2026, U.S. rules allow some medicines to be made this way without FDA approval. This may help a patient who needs a medicine without a dye that causes an allergy, or a form they can swallow. A ready-made medicine may also be unavailable. U.S. rules also limit copying ready-made medicines. The question sheet explains that rule. Read the rule about making copies FDA does not review a compounded medicine’s safety, quality, or ability to work before sale. FDA warns that poor compounding can leave germs in a drug or the wrong amount of the ingredient that does the work. Source C Research use only FDA warns, as of September 2026, against weight-loss products marked for research but offered for people to use. These products have unknown quality and may harm your health. Pause when a treatment offer points you toward a research chemical. Source D Choose a route to care In a room or over a screen Compare a visit in person with a visit by phone or online. With telehealth, you receive care by video, phone, or an online exchange instead of sharing a room with the person treating you. Your location matters. As of September 2026, a doctor giving telehealth care needs permission to practise in the state you are physically in during that visit. Some states let a doctor licensed elsewhere sign up for permission to provide online care, a process called telehealth registration. That permission usually does not allow an office or visits in person in that state. Ask how the service checks that permission, including when you travel. Source E Turn an offer into a conversation What to bring to a visit Your goal, in your own words Write down what bothers you and what you hope to change. Bring the names of your current medicines and your main questions. Space to discuss other options Ask what else might explain the problem. Ask about other treatments, and what happens if you wait. A plan for the next conversation Before agreeing, ask who to reach after the visit, how the plan will be reviewed, and how to get your records. What a check of your health adds Medical boards form a national group called the Federation of State Medical Boards. Guidance from this group, checked in September 2026, says choosing from a treatment menu is not enough. The guidance calls for a check of your health and time to ask questions of the doctor or other health professional who treats you. The guidance also says your treating doctor should arrange the tests you need or send you to someone who can perform them. These are recommendations, not a law that applies in every state; your state’s own rules determine what is legally required. Ask the service how it checks your health, arranges tests, and answers questions. Ask your state medical board which rules apply. Source F Keep the questions together Check the person. Name the medicine. Get the total. Take the question sheet into your next conversation about care. Open the question sheet The page footnotes Read what supports these checks Peptides and drug rules FDA: compounding questions and answers Approved semaglutide products FDA: semaglutide (Wegovy) product label FDA: semaglutide (Ozempic) injection label Compounding and review FDA: how compounding works FDA: limits and risks of compounded drugs U.S. law: rules for medicines made for a patient Research-labelled products FDA: concerns about unapproved weight-loss drugs Permission to practise where you are U.S. health department: getting started with licences U.S. health department: licensing across state lines Assessment and follow-up Medical boards: prescribing and dispensing guidance Medical boards: online care guidance This is a guide to checking care; it offers no treatment and sells no medicine. Read this page as plain text